Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Progressive Encephalomyelitis with Rigidity Responsive to Plasmapheresis and Immunosuppression
Ann Neurol 40:451-453, Fogan,L., 1996
Regional Subacute Cranial Neuropathies Following Internal Carotid Cisplatin Infusion
Neurol 47:1088-1090, Alderson,L.M.,et al, 1996
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Acute Vincristine Neurotoxicity
Lancet 1:346, 637-6381985., Arnold,A.M.,et al, 1985
Nervous System Toxicity of Chemo Agents
Young, DF, in Vinken PJ, Bruyn GW, Handbook of Clin Neurol, North-Holland Publ Co, Amster, Vol 39, 1, 80, p 104, 1980
Recurrent Laryngeal Nerve Paralysis in Patients Receiving Vincristine & Vinblastine
BMJ 1:1251, Whittaker,J.A., 1977
Polymyositis & Dermatomyositis
NEJM 292:344, 1975, 292:403975., Bohan,A.,et al, 1975
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
The Neuromyopathy of Vincristine in Man, Clinical, Electrophysiol & Pathological Studies
J Neurol Sci 10:107-131, Bradley,W.G.,et al, 1970
Ocular Complications of Vincristine Therapy
Arch Ophthalmol 78:709, Albert,D.M.,et al, 1967